Delivery Order SPE2DB22D1202-SPE2DB25FVHG8
- Not listed
- The Defense Logistics Agency awarded a $25,827.06 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 per package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,846.57 for Eliquis 5 mg tablets (60-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed price, non-set-aside contract represents a direct purchase under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $50,375.94 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $49,377.86 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $12,592.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $21,218.77. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.5K to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 22, 2025, with completion expected by September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $7,343.15 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHG8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $48,840.25 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle valued through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal contracting portfolio with the DLA Medical Supply Chain, supplying an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a critical vendor for federal medical procurement, the company fulfills requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Eliquis order supports ongoing pharmaceutical needs within the military healthcare system, with the medication serving as an anticoagulant for stroke prevention and other clinical applications within the Department of Defense medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.8k | 8/13/25 |